COMMON NEUROLOGICAL DISORDERS (E.G., ALZHEIMER'S, PARKINSON'S)

Аннотация

Neurological disorders are a group of conditions that primarily involve the nervous system and are often characterized by progressive dysfunction. Among the most common neurological disorders are Alzheimer’s disease (AD) and Parkinson’s disease (PD), both of which significantly affect cognition, movement, and quality of life. Alzheimer’s disease is the leading cause of dementia, while Parkinson’s disease primarily impacts motor control. This article explores the pathophysiology, clinical features, and current research on these disorders, with a focus on their prevalence, mechanisms, and the latest advancements in treatment. Understanding these diseases is crucial for improving patient outcomes and guiding future research efforts. Keywords: Alzheimer’s Disease, Parkinson’s Disease, Neurodegeneration, Dementia, MotorControl,Neurological Disorders, Pathophysiology, Treatment Introduction: Neurological disorders represent a broad category of diseases that primarily affect the brain, spinal cord, and peripheral nerves. These disorders can impact various aspects of an individual’s functioning, including cognition, motor skills, behavior, and memory. Among the most prevalent and debilitating neurological disorders are Alzheimer’s disease (AD) and Parkinson’s disease (PD), both of which predominantly affect aging populations, although they can also appear in younger individuals in rare cases. These diseases are not only a major cause of disability and morbidity but also significantly burden healthcaresystems worldwide. Alzheimer's disease, which is the most common form of dementia, is a progressive neurodegenerative condition that leads to memory loss, confusion, difficulty with language, and a decline in problem-solving abilities. The disease's hallmark features include the accumulation of amyloid plaques and tau tangles in thebrain, which disrupt normal neuronal communication and cause widespread brain cell death. The onset of symptoms is gradual, often beginning with minor memory lapses before progressing to severe cognitive decline that severely impairs daily living activities. According to the World Health Organization (WHO), the global prevalence of dementia is expected to triple by 2050, largely due to the aging population. Alzheimer’s disease is projected to affect approximately 152 million people globally by 2050, further highlighting the urgent need for effective treatments and preventative strategies. Parkinson’s disease, another common neurological disorder, primarily affects motor function. It is characterized by the degeneration of dopaminergic neurons in the substantia nigra, a part of the brain responsible for controlling voluntary movements. The loss of dopamine, a neurotransmitter involved in motor control, results in the hallmark motor symptoms of PD: tremors, rigidity, bradykinesia (slowness of movement), and postural instability. In addition to these motor symptoms, individuals with Parkinson's disease may experience cognitive decline, sleep disturbances, and mood disorders such as depression and anxiety. It is estimated that over 10 million people worldwide live with Parkinson’s disease, and this number is expected to rise due to the global aging trend. The pathophysiology of Parkinson’s disease involves complex genetic 98,7:ROTCAFTCAPMI.SECNEICSLACIDEM ,5202 ,lirpA,5emuloV gro.srehsilbupcimedaca.www and environmental factors, making its exact cause difficult to pinpoint, although research is ongoing to understand themechanisms at play. Both Alzheimer's and Parkinson's diseases are progressive, incurable, and severely debilitating. These disorders not only affect the individuals diagnosed but also place a significant emotional and financial burden on families and caregivers. As the global population continues to age, the prevalence of these diseases is expected to increase, making itcrucial to enhance understanding, improvediagnosis, anddevelop moreeffective therapies. Literature review Alzheimer's disease (AD) is the most prevalent cause of dementia, characterized by progressive cognitive decline, memory loss, and impaired judgment. The disease’s hallmark features are amyloid-beta plaques and tau tangles, which accumulate in the brain, disrupting normal neuronal function. Amyloid plaques are clumps of a protein called amyloid-beta that accumulate between nerve cells, while tau tangles consist of twisted strands of another protein called tau inside neurons. These abnormal protein aggregations are believed to contribute to neuronal cell death and synaptic dysfunction, leading to the hallmark symptoms ofdementia. A comprehensive review by Hardy and Selkoe (2023) explored the role of amyloid-beta and tau proteins in the pathogenesis of Alzheimer’s disease. They emphasized that amyloid-beta plaques play a critical role in disrupting synaptic function, which contributes to the loss of cognitive abilities. Furthermore, tau tangles exacerbate this damage by destabilizing microtubules, impairing neuro